Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Immuneoncia Therapeutics Inc.

Clinical trials sponsored by Immuneoncia Therapeutics Inc., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

New hope for rare lymphoma: experimental drug IMC-001 tested in 23 patients

Disease control Ongoing

This study tests an experimental drug called IMC-001 in 23 adults with a rare lymphoma (extranodal NK/T-cell lymphoma) that has returned or not improved after prior therapy. The main goal is to see if the drug can shrink tumors. Participants receive the drug and are monitored for…

Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control

Last updated May 02, 2026 18:47 UTC